Kura Oncology, Inc.KURANASDAQ
Loading
Year-over-year operating cash flow growth rate
Latest
245.45%
↑ 2324% vs avg
Percentile
P97
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
10.12%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 245.45% |
| Q3 2025 | -180.18% |
| Q2 2025 | 59.99% |
| Q1 2025 | -126.73% |
| Q4 2024 | 719.55% |
| Q3 2024 | -2.14% |
| Q2 2024 | 12.93% |
| Q1 2024 | -42.37% |
| Q4 2023 | -18.19% |
| Q3 2023 | -13.31% |
| Q2 2023 | 28.59% |
| Q1 2023 | -35.21% |
| Q4 2022 | -26.27% |
| Q3 2022 | 30.75% |
| Q2 2022 | 5.72% |
| Q1 2022 | -37.73% |
| Q4 2021 | 4.99% |
| Q3 2021 | 12.40% |
| Q2 2021 | 1.55% |
| Q1 2021 | -55.76% |
| Q4 2020 | -7.91% |
| Q3 2020 | -15.15% |
| Q2 2020 | 25.67% |
| Q1 2020 | -42.27% |
| Q4 2019 | -14.72% |
| Q3 2019 | 15.84% |
| Q2 2019 | -1.26% |
| Q1 2019 | -39.57% |
| Q4 2018 | 21.46% |
| Q3 2018 | -3.25% |
| Q2 2018 | 2.02% |
| Q1 2018 | -71.94% |
| Q4 2017 | -19.87% |
| Q3 2017 | -2.05% |
| Q2 2017 | 29.13% |
| Q1 2017 | -27.96% |
| Q4 2016 | -23.14% |
| Q3 2016 | 6.06% |
| Q2 2016 | 20.36% |
| Q1 2016 | -30.49% |